Harmony Biosciences Holdings, Inc.
General ticker "HRMY" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $1.9B (TTM average)
Harmony Biosciences Holdings, Inc. follows the US Stock Market performance with the rate: 24.2%.
Estimated limits based on current volatility of 2.5%: low 27.65$, high 29.05$
Factors to consider:
- Total employees count: 268 as of 2024
- US accounted for 100.0% of revenue in the fiscal year ended 2023-12-31
- Top business risk factors: Market acceptance of WAKIX, Regulatory and compliance, Reputation and brand risks, Pandemic risks, Cybersecurity threats
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [30.50$, 46.77$]
- 2026-12-31 to 2027-12-31 estimated range: [31.43$, 48.25$]
Financial Metrics affecting the HRMY estimates:
- Positive: with PPE of 14.1 at the end of fiscal year the price was neutral
- Positive: Operating cash flow per share per price, % of 15.90 > 12.96
- Positive: Operating profit margin, % of 24.00 > 18.38
- Negative: Investing cash flow per share per price, % of -1.81 <= -0.63
- Negative: 0.01 < Interest expense per share per price, % of 0.67
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term HRMY quotes
Long-term HRMY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $582.02MM | $714.73MM | $868.45MM |
| Operating Expenses | $389.99MM | $523.91MM | $659.98MM |
| Operating Income | $192.03MM | $190.83MM | $208.47MM |
| Non-Operating Income | $-18.63MM | $0.98MM | $6.59MM |
| Interest Expense | $23.76MM | $17.50MM | $14.65MM |
| R&D Expense | $76.06MM | $145.82MM | $189.59MM |
| Income(Loss) | $173.40MM | $191.80MM | $215.06MM |
| Taxes | $44.54MM | $46.31MM | $56.38MM |
| Profit(Loss)* | $128.85MM | $145.49MM | $317.37MM |
| Stockholders Equity | $466.99MM | $659.15MM | $870.22MM |
| Inventory | $5.36MM | $7.20MM | $5.36MM |
| Assets | $811.45MM | $999.20MM | $1,271.63MM |
| Operating Cash Flow | $219.39MM | $219.82MM | $348.20MM |
| Capital expenditure | $0.31MM | $1.15MM | $0.31MM |
| Investing Cash Flow | $-46.44MM | $-67.48MM | $-39.65MM |
| Financing Cash Flow | $-105.55MM | $-11.00MM | $-9.05MM |
| Earnings Per Share** | $2.17 | $2.56 | $5.52 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.